Implications of the relationship between maternal age and parity with hepatitis B carrier status in a high endemicity area

Journal of Viral Hepatitis

Volumn 17, Issue 5, 2010, Pages 372-378

  Suen, S S H ^a   Lao, T T ^a   Sahota, D S ^a   Lau, T K ^a   Leung, T Y ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Hepatitis B; Horizontal transmission; Maternal age; Parity pregnancy; Year of birth

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; DISEASE CARRIER; ENDEMIC DISEASE; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MATERNAL AGE; PARITY; PREGNANT WOMAN; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; CARRIER STATE; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HONG KONG; HUMANS; MATERNAL AGE; PARITY; PREGNANCY; PREGNANCY COMPLICATIONS; PREVALENCE; RETROSPECTIVE STUDIES; SEXUAL BEHAVIOR;

EID: 77949769805     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2009.01195.x     Document Type: Article

References (44)

1. Chen CJ, Wang LY, Yu MW. Epidemiology of hepatitis B virus infection in the Asia-Pacific region. J Gastroenterol Hepatol 2000 15 : E3 E6.
2. Ma J, Bauman A. Obstetric profiles and pregnancy outcomes of immigrant women in New South Wales, 1990-1992. Aust NZ J Obstet Gynaecol 1996 36 (2 119 125.
3. Kawsar M, Goh BT. Hepatitis B virus infection among Chinese residents in the United Kingdom. Sex Transm Infect 2002 78 (3 166 168.
4. Wong VC, Ip HM, Reesink HW et al. Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin Double-blind randomised placebo-controlled study. Lancet 1984 1 (8383 921 926.
5. Kwan LC, Ho YY, Lee SS. The declining HbsAg carriage rate in pregnant women in Hong Kong. Epidemiol Infect 1997 119 (2 281 283.
6. Chang MH, Chen CJ, Lai MS et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med 1997 336 (26 1855 1859.
7. Lee AK, Ip HM, Wong VC. Mechanisms of maternal-fetal transmission of hepatitis B virus. J Infect Dis 1978 138 (5 668 671.
8. Lao TT, Chan BC, Leung WC, Ho LF, Tse KY. Maternal hepatitis B infection and gestational diabetes mellitus. J Hepatol 2007 47 (1 46 50.
9. Leung TY, Leung TN, Sahota DS et al. Trends in maternal obesity and associated risks of adverse pregnancy outcomes in a population of Chinese women. BJOG 2008 115 (12 1529 1537.
10. Chan OK, Suen SS, Lao TT, Leung VK, Yeung SW, Leung TY. Determinants of hepatitis B vaccine uptake among pregnant Chinese women in Hong Kong. Int J Gynaecol Obstet 2009 106 (3 232 235.
11. Ip HMH, Lelie PN, Wong VCW, Kuhns MC, Reesink HW. Prevention of hepatitis B virus carrier state in infants according to maternal serum levels of HBV DNA. Lancet 1989 i : 406 410.
12. Ngui SL, Andrews NJ, Underhill GS, Heptonstall J, Teo CG. Failed postnatal immunoprophylaxis for hepatitis B: characteristics of maternal hepatitis B virus as risk factors. Clin Infect Dis 1998 27 : 100 106.
13. Lin HH, Chang MH, Chen DS et al. Early predictor of the efficacy of immunoprophylaxis against perinatal hepatitis B transmission: analysis of prophylaxis failure. Vaccine 1991 9 : 457 460.
14. Del Canho R, Grosheide PM, Schalm SW, de Vries RR, Heijtink RA. Failure of neonatal hepatitis B vaccination: the role of HBV DNA levels in hepatitis B carrier mothers and HLA antigens in neonates. J Hepatol 1994 20 (4 483 486.
15. Lazizi Y, Badur S, Perk Y, Liter O, Pillot J. Selective unresponsiveness to the HBsAg vaccine in newborns related with an in utero passage of hepatitis B virus DNA. Vaccine 1997 15 : 1095 1100.
16. Ingardia CJ, Kelley L, Steinfeld JD, Wax JR. Hepatitis B vaccination in pregnancy: factors influencing efficacy. Obstet Gynecol 1999 93 (6 983 986.
17. Su FH, Chen JD, Cheng SH, Sung KY, Jeng JJ, Chu FY. Waning-off effect of serum hepatitis B surface antibody amongst Taiwanese university students: 18 years post-implementation of Taiwan's nattional hepatitis B vaccination programme. J Viral Hepat 2008 15 (1 14 19.
18. Lu CY, Chiang BL, Chi WK et al. Waning immunity to plasma-derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination. Hepatology 2004 40 (6 1415 1420.
19. Van der Sande MA, Waight P, Mendy M et al. Long-term protection against carriage of hepatitis B virus after infant vaccination. J Infect Dis 2006 193 (11 1528 1535.
20. Hammitt LL, Hennessy TW, Fiore AE et al. Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years. Vaccine 2007 40 : 6958 6964.
21. Chinchai T, Chirathaworn C, Praianantathavorn K et al. Long-term humoral and cellular immune response to hepatitis B vaccine in high-risk children 18-20 years after neonatal immunization. Viral Immunol 2009 22 (2 125 130.
22. Yeoh EK. Prevention and control of hepatitis B infection in Hong Kong. J Hong Kong Med Assoc 1985 1 : 7 12.
23. Leong S, Lin CK, Mak KH. Prevention of transfusion transmitted HIV infection in Hong Kong by blood transfusion service. Int Conf AIDS 1992 8 : D414 (abstract no poD5166).
24. CDC. Sexually transmitted diseases treatment guidelines, 2006. MMWR 2006 55 (RR-11 71 76.
25. Atkins M, Nolan M. Sexual transmission of hepatitis B. Curr Opin Infect Dis 2005 18 (1 67 72.
26. Ko YC, Yen YY, Yeh SM, Lan SJ. Female to male transmission of hepatitis B virus between Chinese spouses. J Med Virol 1989 27 (2 142 144.
27. Gilson RJ, Hawkins AE, Beecham MR et al. Interactions between HIV and hepatitis B virus in homosexual men: effects on the natural history of infection. AIDS 1997 11 (5 597 606.
28. Hudson CP, Hennis AJ, Kataaha P et al. Risk factors for the spread of AIDS in rural Africa: evidence from a comparative seroepidemiological survey of AIDS, hepatitis B and syphilis in southwestern Uganda. AIDS 1988 2 (4 255 260.
29. Bile K, Abdirahman M, Mohamud O et al. Late seroconversion to hepatitis B in a Somali village indicates the important role of venereal transmission. J Trop Med Hyg 1991 94 (6 367 373.
30. Chu CM, Liaw YF. HBsAg seroclearance in asymptomatic carriers of high endemic areas: appreciable high rates during a long-term follow-up. Hepatology 2007 45 (5 1187 1192.
31. Hsu YS, Chien RN, Yeh CT et al. Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B. Hepatology 2002 35 (6 1522 1527.
32. Chen YC, Sheen IS, Chu CM, Liaw YF. Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with or without concurrent infection. Gastroenterology 2002 123 (4 1084 1089.
33. Arase Y, Ikeda K, Suzuki F et al. Long-term outcome after hepatitis B surface antigen seroclearance in patients with chronic hepatitis B. Am J Med 2006 119 (1 71.e9 71.e16.
34. Lindsay KL, Redeker AG, Ashcavai M. Delayed HBsAg clearance in chronic hepatitis B viral infection. Hepatology 1981 1 (6 586 589.
35. Liaw YF, Sheen IS, Chen TJ, Chu CM, Pao CC. Incidence, determinants and significance of delayed clearance of serum HBsAg in chronic hepatitis B infection: a prospective study. Hepatology 1991 13 (4 627 631.
36. Sampliner RE, Hamilton FA, Iseri OA, Tabor E, Boitnott J. The liver histology and frequency of clearance of the hepatitis B surface antigen (HBsAg) in chronic carriers. Am J Med Sci 1979 277 (1 17 22.
37. Arase Y, Suzuki F, Suzuki Y et al. Long-term presence of HBV in the sera of chronic hepatitis B patients with HBsAg seroclearance. Intervirology 2007 50 (3 161 165.
38. Tseng TC, Kao JH. HBsAg seroclearance: the more and earlier, the better. Gastroenterology 2009 136 (5 1842 1843.
39. Alward WL, McMahon BJ, Hall DB, Heyward WL, Francis DP, Bender TR. The long-term serological course of asymptomatic hepatitis B virus carriers and the development of primary hepatocellular carcinoma. J Infect Dis 1985 151 (4 604 609.
40. Huo TI, Wu JC, Lee PC et al. Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis. Hepatology 1998 28 (1 231 236.
41. Yuen MF, Ho Wong DKH, Sahlon E et al. HBsAg seroclearance in chronic hepatitis B in the Chinese: virological, histological, and clinical aspects. Hepatology 2004 39 (6 1694 1701.
42. Yuen MF, Wong DKH, Fung J et al. HBsAg Seroclearance in chronic hepatitis B in Asian patients: replicative level and risk of hepatocellular carcinoma. Gastroenterology 2008 135 (4 1192 1199.
43. Leichtner AM, Leclair J, Goldmann DA, Schumacher RT, Gewolb IH, Katz AJ. Horizontal nonparenteral spread of hepatitis B among children. Ann Intern Med 1981 94 (3 346 349.
44. Ko YC, Li SC, Yen YY, Yeh SM, Hsieh CC. Horizontal transmission of hepatitis B virus from siblings and intramuscular injection among preschool children in a familial cohort. Am J Epidemiol 1991 133 (10 1015 1023.